Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00293514
What this trial is testing

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

Who this might be right for
Pulmonary DiseasesIntraoperative Complications
Nycomed
Very early researchStudy completedNCT00743314
What this trial is testing

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Who this might be right for
Breast CancerLymphedema
Mayo Clinic 30
Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Testing effectiveness (Phase 2)Study completedNCT01853878
What this trial is testing

Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 137
Testing effectiveness (Phase 2)Study completedNCT03179904
What this trial is testing

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaHER2-Positive Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8+2 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00110058
What this trial is testing

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT01298934
What this trial is testing

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Who this might be right for
Primary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis
Ronald Hoffman 22
Very early researchLooking for participantsNCT07558538
What this trial is testing

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital 24
Testing effectiveness (Phase 2)Ended earlyNCT02378038
What this trial is testing

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Who this might be right for
Richter's Transformation
Sierra Oncology LLC - a GSK company 5
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Not applicableNo Longer AvailableNCT05269771
What this trial is testing

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06983899
What this trial is testing

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

Who this might be right for
Lung Non-Small Cell Carcinoma
Fred Hutchinson Cancer Center 100
Testing effectiveness (Phase 2)UnknownNCT04223999
What this trial is testing

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

Who this might be right for
Recurrent Glioblastoma
Anders Rosendal Korshøj 70
Testing effectiveness (Phase 2)WithdrawnNCT04834349
What this trial is testing

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00005943
What this trial is testing

Gene Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Colorado, Denver
Early research (Phase 1)Study completedNCT01149343
What this trial is testing

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer

Who this might be right for
Melanoma
GlaxoSmithKline 107
Testing effectiveness (Phase 2)Ended earlyNCT03911076
What this trial is testing

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

Who this might be right for
ASC-USASC-HLSIL
PapiVax Biotech, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Large-scale testing (Phase 3)WithdrawnNCT00226668
What this trial is testing

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Who this might be right for
Brain EdemaBrain Tumor
Celtic Pharma Development Services 120
Next Page